Vitamin D2 vs D3: Does Taking D2 Actually Lower Your D3 Levels? What the New Research Shows

Vitamin D2 supplementation — the deliberate intake of ergocalciferol, a plant-derived form of vitamin D — can reduce the body's circulating levels of 25-hydroxyvitamin D3 by an average of 9 to 18 nanomoles per liter, according to research published in 2025. That finding challenges the long-held assumption that D2 and D3 are metabolically interchangeable.

For decades, clinicians and supplement manufacturers treated the two forms as functionally equivalent routes to the same destination. Both raise total vitamin D status. Both are converted by the liver into their respective 25-hydroxy metabolites, the forms measured in standard blood tests. A growing body of randomized trial evidence — now synthesized in a landmark meta-analysis from the University of Surrey, John Innes Centre, and Quadram Institute Bioscience — suggests the two forms diverge in ways that matter for everyday supplementation decisions.

How Do Vitamin D2 and D3 Compare at a Glance?

The table below summarizes the key differences between the two forms across the dimensions most relevant to supplement buyers.

Feature	Vitamin D2 (Ergocalciferol)	Vitamin D3 (Cholecalciferol)
Primary source	Fungi, yeast, UV-irradiated plants	Human skin (sunlight), lanolin (sheep's wool), lichen (vegan)
Effect on total 25(OH)D	Raises 25(OH)D2; modest total increase	Raises 25(OH)D3; larger total increase (mean difference ~15.69 nmol/L vs D2)
Effect on circulating D3 metabolites	Reduces 25(OH)D3 by ~9–18 nmol/L	No reduction of D2 metabolites in most people
Parathyroid hormone (PTH) reduction	Significant reduction (confirmed 2026 meta-analysis)	Stronger PTH reduction vs D2 (24-study meta-analysis)
Type I interferon immune signaling	No observed stimulation	Stimulates type I interferon pathway
Suitable for vegans	Yes (standard D2)	Yes, if lichen-derived D3 is used
Duration of effect	Shorter-lived elevation in blood	Sustained elevation for longer period
NIH guidance	Both raise vitamin D; D3 preferred for larger, longer effect	Preferred form per current NIH evidence summary

Sources: University of Surrey / ScienceDaily, Balachandar et al., Nutrients 2021, EurekAlert

What Did the 2025 University of Surrey Study Actually Find?

The 2025 study — published in Nutrition Reviews by Emily Brown, Andrea Darling, and colleagues from the University of Surrey, John Innes Centre, and Quadram Institute Bioscience — is a systematic review and meta-analysis of randomized controlled trials examining the effect of vitamin D2 supplementation on 25-hydroxyvitamin D3 status.

Researchers reviewed 20 studies, with 11 providing data suitable for the main meta-analysis. The pooled sample included 1,080 participants. Compared with people who received no vitamin D2, those who took D2 supplements had significantly lower concentrations of 25-hydroxyvitamin D3 — a reduction ranging from approximately 9 to 18 nmol/L depending on the analytical approach.

Lead researcher Emily Brown stated: "We discovered that vitamin D2 supplements can actually decrease levels of vitamin D3 in the body, which is a previously unknown effect of taking these supplements. This study suggests that subject to personal considerations, vitamin D3 supplements may be more beneficial for most individuals over vitamin D2."

That framing matters. The study does not argue that D2 is dangerous or that it fails to raise vitamin D status altogether. D2 supplementation does increase 25-hydroxyvitamin D2 in the blood, and total vitamin D levels can still rise. The surprising finding is that elevating one form appears to coincide with a measurable reduction in the other — a metabolic trade-off not previously well characterized in the literature.

Why Would Taking D2 Lower Your D3 Levels?

Scientists do not yet have a definitive mechanistic explanation. The biology here remains incompletely understood.

One leading hypothesis involves the body's regulatory machinery for vitamin D catabolism. When vitamin D metabolites accumulate — regardless of which form — the body may upregulate enzymes responsible for breaking them down and clearing them from circulation. If D2 supplementation triggers this clearance response, it could accelerate the disposal of existing 25-hydroxyvitamin D3 alongside the newly introduced D2 metabolites.

Earlier experimental work lends some support to this idea. A randomized controlled trial by Hammami and Yusuf (2017), published in BMC Endocrine Disorders, found a 16.4 nmol/L decrease in 25(OH)D3 levels in D2-treated participants — a reduction that correlated significantly with the rise in 25(OH)D2 (r = 0.48) and with baseline vitamin D status (r = 0.58). In one participant with measurable baseline D2 levels, D3 supplementation caused a similar decrease in D2 metabolites, suggesting the relationship may be bidirectional rather than D2-specific.

The Hammami trial also found that the differential effects of D2 and D3 were dose-, sex-, and time-dependent. Females showed larger responses to both forms, and the gap between D2 and D3 was smaller at lower doses. This nuance matters for interpreting the meta-analysis: the magnitude of D3 suppression may vary considerably depending on how much D2 is taken and individual metabolic factors.

What remains unresolved is whether this suppression of circulating D3 translates into meaningful health consequences — or whether the body compensates adequately through the D2 pathway. That is the central question future research needs to answer.

How Much More Effective Is D3 Than D2 at Raising Overall Vitamin D?

The superiority of D3 over D2 for raising total vitamin D status is one of the more consistent findings in nutritional research. A 2021 systematic review and meta-analysis by Balachandar et al., published in Nutrients and covering 24 studies with 1,277 participants, found that cholecalciferol (D3) raised total 25(OH)D by a mean of 15.69 nmol/L more than ergocalciferol (D2) — a difference that held consistently across varying participant demographics, dosages, and supplementation vehicles.

The same analysis found that D3 was also more effective at reducing parathyroid hormone (PTH) levels, a functional marker of vitamin D adequacy. Elevated PTH is associated with bone loss and calcium dysregulation, so this difference carries clinical relevance beyond a simple blood-level comparison.

The Balachandar meta-regression identified average daily dose as the single most significant predictor of effect size — meaning the D2-versus-D3 gap narrows at lower doses. Someone taking a modest 10 µg (400 IU) daily dose may see less dramatic differences between the two forms than someone taking higher therapeutic doses.

A separate 2026 systematic review and meta-analysis examining 26 randomized trials of vitamin D2 found that D2 supplementation significantly reduced PTH levels and produced a small increase in blood calcium, confirming that D2 retains meaningful biological activity even while it may reduce circulating D3. This finding is a necessary counterweight to any reading of the Surrey study that frames D2 as simply harmful — it is not. It is less efficient, and it appears to suppress D3 metabolites, but it still moves the body's calcium-regulatory machinery in the right direction.

Does D3 Have Immune Benefits That D2 Lacks?

This is where the research becomes particularly intriguing — and where the most caution is warranted in interpretation.

A study led by Professor Colin Smith from the University of Surrey, published in Frontiers in Immunology, examined how D2 and D3 supplementation affected gene expression in blood cells. The researchers found substantial differences in the transcriptional responses to the two forms. Vitamin D3 appeared to stimulate activity associated with type I interferon signaling; vitamin D2 did not produce the same effect.

Type I interferons are a family of signaling proteins that alert cells to the presence of an infection and coordinate the body's early antiviral and antibacterial defenses. They are among the first responders in innate immunity — the non-specific, rapid-response arm of the immune system that acts before the adaptive immune response (antibodies, T-cells) can mobilize.

Professor Smith stated: "We have shown that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signalling system in the body — a key part of the immune system that provides a first line of defence against bacteria and viruses. Thus, a healthy vitamin D3 status may help prevent viruses and bacteria from gaining a foothold in the body."

That is a striking claim, but it requires careful framing. Changes in gene expression and immune signaling patterns do not automatically translate into fewer infections or better clinical outcomes. The interferon findings come from a gene-activity study, not a clinical trial measuring rates of illness. Larger, longer-term studies are needed before anyone can responsibly say that taking D3 instead of D2 will meaningfully reduce your chances of catching a respiratory virus.

What the immune data does establish is that D2 and D3 are not biologically identical in their downstream effects — a point that strengthens the case for treating them as distinct compounds rather than interchangeable labels.

Who Is Most Affected by the D2-Lowers-D3 Finding?

The practical impact of the D3-suppression effect depends heavily on a person's baseline vitamin D status and their reason for supplementing.

For someone with adequate vitamin D levels taking a low-dose D2 supplement, the 9–18 nmol/L reduction in circulating D3 may not push them into deficiency territory. Vitamin D blood levels below 30 nmol/L are generally considered to be associated with poor health outcomes, and many people in the UK and other northern-latitude countries start the winter months with levels well above that threshold.

For someone already borderline-deficient — which Verywell Health notes is a significant proportion of the UK population during winter months — a nearly 18 nmol/L drop in the more effective form of vitamin D could be clinically meaningful. Emily Brown told Verywell: "It's not necessarily endangering people of deficiency. However, it's a really significant drop."

The groups most likely to be affected include:

People in northern latitudes (UK, Scandinavia, northern North America) during October–March, when skin synthesis of D3 from sunlight is negligible
Older adults, who synthesize D3 from sunlight less efficiently
People with darker skin tones, who require more sun exposure to produce equivalent amounts of D3
Anyone with a baseline vitamin D level in the 30–50 nmol/L range, where an 18 nmol/L reduction could tip them toward insufficiency

What About Vegans and Plant-Based Eaters?

Vitamin D3 is traditionally derived from lanolin — a waxy substance extracted from sheep's wool — making standard D3 supplements unsuitable for vegans and many vegetarians. This is the primary reason D2 has historically been the default recommendation for plant-based eaters: it comes from fungi and yeast exposed to ultraviolet light, with no animal involvement.

The Surrey research team and commentators on the study are careful to acknowledge this reality. Professor Cathie Martin stated: "This meta-analysis highlights the importance of ensuring plant-based vitamin D3 is accessible in the UK."

Plant-based D3 is now commercially available. Lichen — a symbiotic organism formed from algae and fungi — naturally produces vitamin D3, and lichen-derived cholecalciferol is now used in vegan D3 supplements. Registered dietitian Sue-Ellen Anderson-Haynes, speaking to Verywell Health, framed the priority clearly: "As a plant-based dietitian, I would say that taking a vitamin D supplement when you need it, after you have spoken to a provider, is the priority. It's all up to you if you want to take D3 or D2."

For vegans who cannot access or afford lichen-derived D3, D2 remains a meaningful option — one that still raises total vitamin D status and reduces PTH, even if it does so less efficiently and with the added complication of reducing circulating D3. Taking no supplement at all is almost certainly worse for most people in vitamin D-deficient environments.

If you follow a plant-based diet and are interested in omega-3 supplementation alongside vitamin D, algae-derived DHA supplements offer a similarly animal-free route to nutrients typically associated with fish oil.

How Much Vitamin D Do You Actually Need?

The UK government advises adults to consider taking 10 micrograms (µg) — approximately 400 IU — of vitamin D daily during the autumn and winter months, when sunlight is insufficient for skin synthesis. The U.S. Recommended Dietary Allowance sits at 600 IU for adults up to age 70 and 800 IU for those older.

Professor JoAnn Manson of Harvard Medical School, quoted by Verywell Health, noted that the body's vitamin D metabolism is tightly regulated and most people do not need megadoses. Excessive supplementation — particularly at doses above 4,000 IU daily sustained over time — can cause hypercalcemia, kidney stones, and other adverse effects.

The D2-versus-D3 debate is most relevant in the context of standard supplementation doses. At very high therapeutic doses, sometimes used to correct severe deficiency under medical supervision, the metabolic differences between the two forms may be amplified — but that is a clinical scenario requiring professional guidance and regular blood monitoring.

What Do Researchers Still Need to Figure Out?

The 2025 Surrey meta-analysis is a significant step forward, but it leaves several important questions unanswered.

The most pressing is whether the reduction in circulating 25-hydroxyvitamin D3 caused by D2 supplementation produces measurable differences in health outcomes — bone density, infection rates, muscle function, or long-term disease risk. The meta-analysis demonstrates a biochemical effect; it does not demonstrate a clinical consequence.

Researchers also need to clarify the mechanism. Is the D3 suppression driven by shared catabolic enzymes? By competitive binding to transport proteins? By feedback regulation of vitamin D synthesis pathways? Understanding the mechanism would help predict which populations are most vulnerable and at what doses the effect becomes clinically significant.

Professor Martin Warren of the Quadram Institute captured the public health stakes: "Vitamin D deficiency represents a significant public health concern, especially during the winter months with significant deficiency across the UK population. Tackling this with the most effective form of vitamin D supplementation or fortification is of the utmost importance to the health of the nation."

There is also a fortification question. Many foods — dairy milks, plant-based milks, cereals — are fortified with vitamin D, and the form used varies by manufacturer. If D2 fortification at population scale suppresses D3 levels in people who are simultaneously getting some sun exposure, the net effect on public health could be meaningful. This has not been studied at scale.

Should You Switch From D2 to D3?

The evidence increasingly favors D3 for most people, but the answer is not a simple universal yes — it depends on individual circumstances.

For people without dietary restrictions, the case for choosing D3 over D2 is now fairly strong. D3 raises total vitamin D status more effectively, sustains that elevation for longer, does not appear to suppress D2 metabolites in most people, and may activate immune pathways that D2 does not. The NIH's current guidance already reflects this, noting that D3 tends to raise vitamin D levels more and keep them elevated for longer.

For vegans and plant-based eaters, the calculus is more detailed. Standard D2 remains widely available and inexpensive, and it still raises total vitamin D status. Lichen-derived D3 is the preferred alternative, but it is less widely distributed and typically more expensive. Anyone in this situation should discuss options with a healthcare provider, particularly if they live at a northern latitude and have limited sun exposure during winter.

For people currently taking D2 under medical supervision — for example, as a prescription-strength dose to correct documented deficiency — the Surrey findings do not constitute grounds for self-discontinuation. The 2026 meta-analysis confirms D2 still has meaningful biological effects, including PTH reduction. Any change to a prescribed supplement regimen should be made in consultation with a clinician who can assess blood levels and adjust accordingly.

The label on a vitamin D supplement matters more than previously recognized. D2 and D3 are not metabolically interchangeable, and the accumulated evidence now gives D3 a meaningful advantage for most supplementation scenarios. What science still needs to establish — and what future trials must address — is whether those biochemical differences translate into the health outcomes that matter most to the people taking these supplements every day.